bioAffinity Technologies, Inc. — Director's Dealing 2024

Mar 29, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: bioAffinity Technologies, Inc. (BIAF)
CIK: 0001712762
Period of Report: 2024-02-26

Reporting Person: Anderson Robert A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-26	Common Stock	M	64848	$1.155	Acquired	121856	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-26	Stock Option (right to buy)	$1.115	M	64848	Disposed	2024-04-28	Common Stock (64848)	Direct

Footnotes

F1: This option vested in 7 equal monthly installments beginning on May 28, 2014 and the balance of such option vested on December 28, 2014.